120 related articles for article (PubMed ID: 37274797)
1. TATA-box-binding protein-associated factor 15 is a novel biomarker that promotes cell proliferation and migration in gastrointestinal stromal tumor.
Guo CM; Tang L; Li X; Huang LY
World J Gastroenterol; 2023 May; 29(19):2932-2949. PubMed ID: 37274797
[TBL] [Abstract][Full Text] [Related]
2. TAF15 promotes cell proliferation, migration and invasion of gastric cancer via activation of the RAF1/MEK/ERK signalling pathway.
Tang L; Guo C; Li X; Zhang B; Huang L
Sci Rep; 2023 Apr; 13(1):5846. PubMed ID: 37037864
[TBL] [Abstract][Full Text] [Related]
3. Raf kinase inhibitor protein combined with phosphorylated extracellular signal-regulated kinase offers valuable prognosis in gastrointestinal stromal tumor.
Qu WZ; Wang L; Chen JJ; Wang Y
World J Gastroenterol; 2023 Jul; 29(26):4200-4213. PubMed ID: 37475847
[TBL] [Abstract][Full Text] [Related]
4. Neferine inhibits growth and migration of gastrointestinal stromal tumor cell line GIST-T1 by up-regulation of miR-449a.
Xue F; Liu Z; Xu J; Xu X; Chen X; Tian F
Biomed Pharmacother; 2019 Jan; 109():1951-1959. PubMed ID: 30551450
[TBL] [Abstract][Full Text] [Related]
5. Platelet-Derived Growth Factor Receptor-α Regulates Proliferation of Gastrointestinal Stromal Tumor Cells With Mutations in KIT by Stabilizing ETV1.
Hayashi Y; Bardsley MR; Toyomasu Y; Milosavljevic S; Gajdos GB; Choi KM; Reid-Lombardo KM; Kendrick ML; Bingener-Casey J; Tang CM; Sicklick JK; Gibbons SJ; Farrugia G; Taguchi T; Gupta A; Rubin BP; Fletcher JA; Ramachandran A; Ordog T
Gastroenterology; 2015 Aug; 149(2):420-32.e16. PubMed ID: 25865047
[TBL] [Abstract][Full Text] [Related]
6. ADRB2 Regulates the Proliferation and Metastasis of Gastrointestinal Stromal Tumor Cells by Enhancing the ETV1-c-KIT Signaling.
Chen S; Wu F; Zhang J; Zhu J; Zhou X; Zhi X
J Oncol; 2023; 2023():6413796. PubMed ID: 36778918
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Bmi-1 gene in the development of gastrointestinal stromal tumor by regulating p16
Wang JL; Wu JH; Hong C; Wang YN; Zhou Y; Long ZW; Zhou Y; Qin HS
Pathol Res Pract; 2017 Dec; 213(12):1542-1551. PubMed ID: 29042141
[TBL] [Abstract][Full Text] [Related]
8. Targeting the WEE1 kinase strengthens the antitumor activity of imatinib via promoting KIT autophagic degradation in gastrointestinal stromal tumors.
Liu W; Zeng X; Yin Y; Li C; Yang W; Wan W; Shi L; Wang G; Tao K; Zhang P
Gastric Cancer; 2020 Jan; 23(1):39-51. PubMed ID: 31197522
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA SNHG4 enhances RNF14 mRNA stability to promote the progression of colorectal cancer by recruiting TAF15 protein.
Lv L; Huang B; Yi L; Zhang L
Apoptosis; 2023 Apr; 28(3-4):414-431. PubMed ID: 36482019
[TBL] [Abstract][Full Text] [Related]
10. Integrated Screens Identify CDK1 as a Therapeutic Target in Advanced Gastrointestinal Stromal Tumors.
Lu X; Pang Y; Cao H; Liu X; Tu L; Shen Y; Jia X; Lee JC; Wang Y
Cancer Res; 2021 May; 81(9):2481-2494. PubMed ID: 33727226
[TBL] [Abstract][Full Text] [Related]
11. Antitumor effect of the tyrosine kinase inhibitor nilotinib on gastrointestinal stromal tumor (GIST) and imatinib-resistant GIST cells.
Sako H; Fukuda K; Saikawa Y; Nakamura R; Takahashi T; Wada N; Kawakubo H; Takeuchi H; Ohmori T; Kitagawa Y
PLoS One; 2014; 9(9):e107613. PubMed ID: 25221952
[TBL] [Abstract][Full Text] [Related]
12. Sorafenib induces growth suppression in mouse models of gastrointestinal stromal tumor.
Huynh H; Lee JW; Chow PK; Ngo VC; Lew GB; Lam IW; Ong HS; Chung A; Soo KC
Mol Cancer Ther; 2009 Jan; 8(1):152-9. PubMed ID: 19139124
[TBL] [Abstract][Full Text] [Related]
13. Proteomic Characterization Identifies Clinically Relevant Subgroups of Gastrointestinal Stromal Tumors.
Sun M; Tong Y; Yuan W; Wang Y; Pu Y; Huang W; Lv B; Xu C; Jiang W; Luo R; Fang R; Tang S; Ren L; Wang J; Feng J; Sun C; Shen K; He F; Hou Y; Ding C
Gastroenterology; 2024 Mar; 166(3):450-465.e33. PubMed ID: 37995868
[TBL] [Abstract][Full Text] [Related]
14. Enhancer of zeste homolog 2-mediated paired box 8 methylation promotes gastrointestinal stromal tumor progression through Wnt4 downregulation.
Miao Z; Wu F; Wei H; Luo Z; Wu K; Zhang J
Cancer Gene Ther; 2021 Nov; 28(10-11):1162-1174. PubMed ID: 33479444
[TBL] [Abstract][Full Text] [Related]
15. Histone demethylase KDM4D promotes gastrointestinal stromal tumor progression through HIF1β/VEGFA signalling.
Hu F; Li H; Liu L; Xu F; Lai S; Luo X; Hu J; Yang X
Mol Cancer; 2018 Jul; 17(1):107. PubMed ID: 30060750
[TBL] [Abstract][Full Text] [Related]
16. FGFR-Mediated Reactivation of MAPK Signaling Attenuates Antitumor Effects of Imatinib in Gastrointestinal Stromal Tumors.
Li F; Huynh H; Li X; Ruddy DA; Wang Y; Ong R; Chow P; Qiu S; Tam A; Rakiec DP; Schlegel R; Monahan JE; Huang A
Cancer Discov; 2015 Apr; 5(4):438-51. PubMed ID: 25673643
[TBL] [Abstract][Full Text] [Related]
17. RACK1 overexpression is linked to acquired imatinib resistance in gastrointestinal stromal tumor.
Gao X; Xue A; Fang Y; Shu P; Ling J; Hou Y; Shen K; Qin J; Sun Y; Qin X
Oncotarget; 2016 Mar; 7(12):14300-9. PubMed ID: 26893362
[TBL] [Abstract][Full Text] [Related]
18. miR-4510 acts as a tumor suppressor in gastrointestinal stromal tumor by targeting APOC2.
Chen Y; Qin C; Cui X; Geng W; Xian G; Wang Z
J Cell Physiol; 2020 Jul; 235(7-8):5711-5721. PubMed ID: 31975384
[TBL] [Abstract][Full Text] [Related]
19. THZ1 targeting CDK7 suppresses c-KIT transcriptional activity in gastrointestinal stromal tumours.
Sun J; Zhang Q; Sun X; Xue A; Gao X; Shen K
Cell Commun Signal; 2022 Sep; 20(1):138. PubMed ID: 36076237
[TBL] [Abstract][Full Text] [Related]
20. FoxM1 is regulated by both HIF-1α and HIF-2α and contributes to gastrointestinal stromal tumor progression.
Bai C; Liu X; Qiu C; Zheng J
Gastric Cancer; 2019 Jan; 22(1):91-103. PubMed ID: 29948390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
